Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.5500 (3.27%) ($19.3500 - $20.6500) on Tue. Nov. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.72% (three month average) | RSI | 64 | Latest Price | $20.5500(3.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(56%) ARKG(50%) IBB(50%) IWO(47%) ARKK(46%) | Factors Impacting ATRA price | ATRA will decline at least -2.36% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-10%) UNG(-3%) BNDX(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.36% (StdDev 4.72%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
5 Day Moving Average | $19.6(4.85%) | 10 Day Moving Average | $19.12(7.48%) | 20 Day Moving Average | $18.26(12.54%) | To recent high | -5.8% | To recent low | 60.5% | Market Cap | $1.527b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |